Bristol-Myers Squibb’s have revealed continued strong sales of the anti-blood clotting treatment Plavix and the antipsychotic Abilify and a huge …
The government is to undertake what it calls “a rigorous procurement programme” to look for a suitable shingles vaccine. Possibilities …
Cephalon has promoted Alain Aragues to executive vice president and president of Cephalon Europe. He joined Cephalon in 2002 to …

Now is traditionally a time for both reflection and forward planning, of wiping the slate clean and making a fresh …
McCann Healthcare Worldwide has tasked four senior executives with leading the company through a new ‘chief executive team’. They are …
The times they are a changin’ and not just according to Bob Dylan. It’s hard to go to any UK …

Obesity is about to get the Hollywood treatment with GlaxoSmithKline Consumer Healthcare funding a documentary by Oscar-winning director Barry Levinson. …

In this week’s roundup: PM Society to recognise Digital Media Pioneer, ABPI expands Twitter use, DH accredits health information and …
Pharmaceutical and medical device recalls more than quadrupled in the UK between 2004 and 2008, with the majority caused by …

UK pharma industry association the ABPI has named GSK’s UK general manager Simon Jose its next president. He will take …

Novartis’ long-standing chief executive and chairman, Daniel Vasella is to step down from his dual position to focus upon his …

Ever since the FDA announced its social media and internet hearing last September the big question over here has been …
ScopeMedical has appointed new medical writer Jennifer Duffy (pictured left) and events manager Andrew Wightman. Jennifer has an MSc in …

Pfizer has released details of its new consolidated pipeline following its merger with Wyeth, announcing new priority research areas, and …

The FDA has approved Novo Nordisk’s Victoza a new once-daily injection for patients with type II diabetes. The drug will …
London-based cellular therapeutics company Cell Medica has made four key appointments. Dr Rainer Knaus joins the company as senior vice …

BMS’s Orencia has been approved in Europe to treat children aged six and over who suffer from a form of …
AstraZeneca’s ongoing US legal battle over its antipsychotic drug Seroquel was highlighted this week in a BBC radio programme. AstraZeneca …
GlaxoSmithKline chief executive Andrew Witty has hailed a new UK government ‘blueprint’ to help improve the country’s competitiveness in the …
Packaging and processing technology specialist Romaco has kitted out Indian drugmaker Ankur Drugs and Pharma with a production line for …